Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of EmoDTx as a Digital Endpoint for Mood Monitoring in Adult Patients With Unipolar Depression: An Observational Study Against Standard Depression Assessment Questionnaires

NCT06860165 is registered in ClinicalTrials.gov with Emobot as lead sponsor.

NCT NCT06860165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06860165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of EmoDTx as a Digital Endpoint for Mood Monitoring in Adult Patients With Unipolar Depression: An Observational Study Against Standard Depression Assessment Questionnaires
Lead sponsor
Emobot
Phase
Observational
Overall status
Recruiting
Start date
July 15, 2025
Completion date
December 9, 2025
Enrollment
98 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression, major depressive disorder (mdd), unipolar depression